Crexendo director granted new stock options

Crexendo, Inc. director Kim L Jasmine reported compensation-related grants of stock options.

(Moderate)

(Neutral)

Form Type

Rhea-AI Filing Summary

Crexendo, Inc. director Kim L Jasmine reported compensation-related grants of stock options. She received stock options covering 10,000 shares of common stock with an exercise price of $6.47 per share that vest over 24 equal monthly installments beginning on April 5, 2024 and expire on March 5, 2026. A second grant covers 10,000 shares at $5.77 per share, vesting over 24 equal monthly installments beginning on April 5, 2025 and expiring on March 4, 2035. A third grant covers 15,000 shares at $5.36 per share, vesting over 36 equal monthly installments beginning on April 4, 2026 and expiring on March 5, 2034. These awards are reported as directly owned and reflect option grants rather than open-market share purchases or sales.

Insider Trade Summary

Grant/Award: 35,000 shares

Grant/Award 3 txns

Insider Kim L Jasmine

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Options	15,000	$5.36	$80K
Grant/Award	Stock Options	10,000	$5.77	$58K
Grant/Award	Stock Options	10,000	$6.47	$65K

Holdings After Transaction: Stock Options — 35,000 contracts (Direct)

Footnotes (3)

F1. The stock options vested over 24 equal monthly installments that began on 4/5/2024.
F2. The stock options vest over 24 equal monthly installments beginning on 4/5/2025.
F3. The stock options vest over 36 equal monthly installments beginning on 4/4/2026.

Key Figures

Option grant size: 10,000 stock options Option grant size: 10,000 stock options Option grant size: 15,000 stock options +3 more

6 metrics

Option grant size 10,000 stock options Exercise price $6.47, expiration March 5, 2026

Option grant size 10,000 stock options Exercise price $5.77, expiration March 4, 2035

Option grant size 15,000 stock options Exercise price $5.36, expiration March 5, 2034

Vesting schedule 24 monthly installments Beginning April 5, 2024 for one 10,000-option grant

Vesting schedule 24 monthly installments Beginning April 5, 2025 for one 10,000-option grant

Vesting schedule 36 monthly installments Beginning April 4, 2026 for 15,000-option grant

Key Terms

Stock Options, exercise price, expiration date, underlying security, +1 more

5 terms

Stock Options financial

"The stock options vested over 24 equal monthly installments that began on 4/5/2024."

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

exercise price financial

"conversion_or_exercise_price": "6.4700""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date": "2026-03-05T00:00:00.000Z""

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

underlying security financial

"underlying_security_title": "Common Stock""

equal monthly installments financial

"The stock options vest over 36 equal monthly installments beginning on 4/4/2026."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Crexendo (CXDO) director Kim L Jasmine report on this Form 4?

Director Kim L Jasmine reported receiving three grants of stock options as compensation, covering 10,000, 10,000, and 15,000 shares of Crexendo common stock at exercise prices between $5.36 and $6.47 per share, with multi-year vesting schedules and stated expiration dates.

Were there any open-market buys or sells by Kim L Jasmine in Crexendo (CXDO)?

The filing only shows option grants classified as acquisitions under code A, not open-market purchases or sales. These are compensation awards giving rights to buy Crexendo common stock in the future at fixed exercise prices, subject to vesting conditions over 24 or 36 months.

What are the key terms of the new Crexendo (CXDO) stock options granted to Kim L Jasmine?

The options have exercise prices of $6.47, $5.77, and $5.36 per share, with expirations on March 5, 2026, March 4, 2035, and March 5, 2034. Vesting occurs in equal monthly installments over 24 or 36 months, starting in 2024, 2025, and 2026.

How do the Crexendo (CXDO) option grants to Kim L Jasmine vest over time?

One 10,000-share grant vests over 24 equal monthly installments beginning April 5, 2024. A second 10,000-share grant vests over 24 monthly installments starting April 5, 2025. The 15,000-share grant vests over 36 monthly installments beginning April 4, 2026, aligning vesting with longer service.

Are the reported Crexendo (CXDO) stock options held directly by Kim L Jasmine?

Yes. The Form 4 classifies ownership of each stock option grant as direct, using ownership code "D" and indicating direct beneficial ownership. There are no footnotes in this filing indicating indirect holdings through entities, trusts, or related parties for these specific awards.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 05/20/2026 - 08:48 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kim L Jasmine

(Last)

(First)

(Middle)

1225 W WASHINGTON ST

STE 213

(Street)

TEMPE

ARIZONA

85288

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Crexendo, Inc. [ CXDO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/05/2024

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Options	$5.36	03/05/2024		A		15,000		⁽¹⁾	03/05/2034	Common Stock	15,000	$5.36	15,000	D
Stock Options	$5.77	03/04/2025		A		10,000		⁽²⁾	03/04/2035	Common Stock	10,000	$5.77	10,000	D
Stock Options	$6.47	03/04/2026		A		10,000		⁽³⁾	03/05/2026	Common Stock	10,000	$6.47	10,000	D

Explanation of Responses:

1. The stock options vested over 24 equal monthly installments that began on 4/5/2024.

2. The stock options vest over 24 equal monthly installments beginning on 4/5/2025.

3. The stock options vest over 36 equal monthly installments beginning on 4/4/2026.

Remarks:

This Form 4 is being filed late due to the reporting person not previously having EDGAR filing access credentials. The reporting person is now current with their filings.

	/s/ L Jasmine Kim	05/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

Crexendo director granted new stock options

Rhea-AI Filing Summary

Positive

Negative